Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ravi Bhatia

Showing results (131-140 of 220) with videos related to

Pageof 22
Sort By:
Blood|November 3, 2007
CREB is a critical regulator of normal hematopoiesis and leukemogenesisJerry C Cheng, Kentaro Kinjo, Dejah R Judelson, et al.
JCO Oncology Practice|October 10, 2022
Using Teamwork to Bridge the Adolescent and Young Adult GapJulie A Wolfson, Smita Bhatia, Ravi Bhatia, et al.
Blood|October 26, 2006
The effects of imatinib mesylate treatment before allogeneic transplantation for chronic myeloid leukemiaVivian G Oehler, Ted Gooley, David S Snyder, et al.
Blood|December 18, 2014
MicroRNA-486 regulates normal erythropoiesis and enhances growth and modulates drug response in CML progenitorsLi-Sheng Wang, Ling Li, Liang Li, et al.
Blood Advances|February 24, 2026
Long-term Health Outcomes in Older Blood or Marrow Transplantation Recipients: A Report from the BMTSSRusha Bhandari, Qingrui Meng, Lindsey Hageman, et al.
Science Translational Medicine|September 9, 2016
Combined targeting of BCL-2 and BCR-ABL tyrosine kinase eradicates chronic myeloid leukemia stem cellsBing Z Carter, Po Yee Mak, Hong Mu, et al.
Experimental Hematology|December 23, 2008
Combined BCR-ABL inhibition with lentiviral-delivered shRNA and dasatinib augments induction of apoptosis in Philadelphia-positive cellsSvetlana Myssina, G Vignir Helgason, Alan Serrels, et al.
Blood|October 31, 2013
Leukemia cell-targeted STAT3 silencing and TLR9 triggering generate systemic antitumor immunityDewan Md Sakib Hossain, Cedric Dos Santos, Qifang Zhang, et al.
Leukemia Research|April 29, 2022
Tumor lysis syndrome and infectious complications during treatment with venetoclax combined with azacitidine or decitabine in patients with acute myeloid leukemiaSankalp Arora, Carl Zainaldin, Srilakshmi Bathini, et al.
The Journal of Biological Chemistry|September 9, 2020
Exploitation of dihydroorotate dehydrogenase (DHODH) and p53 activation as therapeutic targets: A case study in polypharmacologyMarcus J G W Ladds, Gergana Popova, Andrés Pastor-Fernández, et al.
Pageof 22

Showing results (131-140 of 220) with videos related to

Sort By:
Pageof 22
Blood|November 3, 2007
CREB is a critical regulator of normal hematopoiesis and leukemogenesisJerry C Cheng, Kentaro Kinjo, Dejah R Judelson, et al.
JCO Oncology Practice|October 10, 2022
Using Teamwork to Bridge the Adolescent and Young Adult GapJulie A Wolfson, Smita Bhatia, Ravi Bhatia, et al.
Blood|October 26, 2006
The effects of imatinib mesylate treatment before allogeneic transplantation for chronic myeloid leukemiaVivian G Oehler, Ted Gooley, David S Snyder, et al.
Blood|December 18, 2014
MicroRNA-486 regulates normal erythropoiesis and enhances growth and modulates drug response in CML progenitorsLi-Sheng Wang, Ling Li, Liang Li, et al.
Blood Advances|February 24, 2026
Long-term Health Outcomes in Older Blood or Marrow Transplantation Recipients: A Report from the BMTSSRusha Bhandari, Qingrui Meng, Lindsey Hageman, et al.
Science Translational Medicine|September 9, 2016
Combined targeting of BCL-2 and BCR-ABL tyrosine kinase eradicates chronic myeloid leukemia stem cellsBing Z Carter, Po Yee Mak, Hong Mu, et al.
Experimental Hematology|December 23, 2008
Combined BCR-ABL inhibition with lentiviral-delivered shRNA and dasatinib augments induction of apoptosis in Philadelphia-positive cellsSvetlana Myssina, G Vignir Helgason, Alan Serrels, et al.
Blood|October 31, 2013
Leukemia cell-targeted STAT3 silencing and TLR9 triggering generate systemic antitumor immunityDewan Md Sakib Hossain, Cedric Dos Santos, Qifang Zhang, et al.
Leukemia Research|April 29, 2022
Tumor lysis syndrome and infectious complications during treatment with venetoclax combined with azacitidine or decitabine in patients with acute myeloid leukemiaSankalp Arora, Carl Zainaldin, Srilakshmi Bathini, et al.
The Journal of Biological Chemistry|September 9, 2020
Exploitation of dihydroorotate dehydrogenase (DHODH) and p53 activation as therapeutic targets: A case study in polypharmacologyMarcus J G W Ladds, Gergana Popova, Andrés Pastor-Fernández, et al.
Pageof 22